New technology that automates breast cancer diagnosis could help prevent thousands of women receiving unnecessary treatment, according to a UK start-up company. A team of Cambridge University graduates is hoping to turn the genetic diagnosis system into a method for determining how likely a tumour is to spread. The researchers claim this would mean at least half of the women currently diagnosed with certain breast cancers in the UK could avoid treatment they would otherwise receive because of the limits of existing screening techniques. 'We've identified that 50-80 per cent of cases of early-stage breast cancer don't progress to become invasive in the next 20 years,' said Hind Kraytem, biomedical engineer and chief executive officer of the team's company Radial Genomics.
展开▼
